Myovant Sciences Ltd. Deferred Offering Costs
Myovant Sciences Ltd. had Deferred Offering Costs of $1.67 million as of 2016-09-30, per its 10-Q filed 2016-12-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2016-12-09
- 2016-09-30: Deferred Offering Costs $1.67M.
- 2016-03-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2016-09-30 | $1.67M 10-Q · filed 2016-12-09 |
| 2016-03-31 | $0.00 10-Q · filed 2016-12-09 |